Tudor Investment Corp
IMCR icon

Tudor Investment Corp’s Immunocore IMCR Stock Holding History

Tudor Investment Corp’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,231
Closed -$719K – 3942
2025
Q4 		$772K Buy
22,231
+1,092
+5% +$38.5K ﹤0.01% 2458
2025
Q3 		$768K Hold
21,139
– – ﹤0.01% 2443
2025
Q2 		$663K Sell
21,139
-33,354
-61% -$1.04M ﹤0.01% 2405
2025
Q1 		$1.62M Buy
+54,493
New +$1.63M 0.01% 1488

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Tudor Investment Corp's IMCR Position: Q1 2026 in Review

Tudor Investment Corp sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 22,231 shares — an estimated $719K sold.

Tudor Investment Corp first reported a position in IMCR in Q1 2025 and held it in 4 quarters. The position peaked at $1.62M in Q1 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Tudor Investment Corp reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 22,231 Immunocore shares in Q1 2026, an estimated $719K.
  • Tudor Investment Corp first reported a position in Immunocore in Q1 2025 and held it in 4 quarters.
  • Tudor Investment Corp's Immunocore position peaked at $1.62M in Q1 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.